UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing

LONDON, May 8 (Reuters) - Autolus Therapeutics, a small British company developing cell therapy treatments, is to join the swelling ranks of listed biotech companies using the new anti-cancer technology with a planned IPO on Nasdaq.